
Medicine and Health
Overcoming resistance to BRAF V600E inhibition in melanoma by deciphering and targeting personalized protein network alterations
S. Vasudevan, E. Flashner-abramson, et al.
This groundbreaking study by S. Vasudevan, E. Flashner-Abramson, and colleagues unveils a personalized approach to combating BRAF V600E melanoma relapses. By utilizing high-resolution signaling signatures to craft individualized drug combinations, the research demonstrates remarkable efficacy compared to standard therapies, offering new hope for patients facing drug resistance.
Playback language: English
Related Publications
Explore these studies to deepen your understanding of the subject.